Luminescent Re(I)/Au(I) Species As Selective Anticancer Agents for HeLa Cells by Luengo, A. et al.
Luminescent Re(I)/Au(I) Species As Selective Anticancer Agents for
HeLa Cells
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ABSTRACT: A series of neutral and cationic heterotrimetallic complexes
of the type fac-[Re(CO)3(bipy(CC)2-(AuL)2)X]
n, where bipy(CC)2 is
4,4′-alkynyl-2,2′-bipyridine; L is either triphenylphosphine (PPh3), [1,3-
bis(2,6-diisopropylphenyl)-imidazol-2-ylidene] (IPr), or tert-butyl iso-
cyanide (CNtBu); and X is a chloride (n = 0) or acetonitrile (n = 1), were
synthesized and characterized together with their Re(I) precursors, i.e.,
fac-[Re(CO)3(bipy(CC)2)X]
n. X-ray diffraction of complexes 1, 3, and 6
corroborated the expected octahedral and linear distribution of the ligands
along the Re(I) and Au(I) centers, respectively. Luminescent studies
showed that all the complexes displayed a broad emission band centered
between 565 and 680 nm, corresponding to a 3MLCT from the Re(I) to
the diimine derivative. The presence of the gold fragment coordinated to the diimine ligand shifted in all cases the emission maxima
toward higher energies. Such an emission difference could be potentially used for assessing the precise moment of interaction of the
probe with the biological target if the gold fragment is implicated. Antiproliferative studies in cancer cells, A549 (lung cancer) and
HeLa (cervix cancer), showed a generalized selectivity toward HeLa cells for those heterotrimetallic species incubated at longer
times (72 vs 24 h). ICP-MS spectrometry revealed the greater cell internalization of cationic vs neutral species. Preliminary
fluorescence microscopy experiments showed a different behavior of the complexes in HeLa and A549 cell lines. Whereas the
complexes in A549 were randomly distributed in the outside of the cell, those incubated with HeLa cells were located close to the
cellular membrane, suggesting some type of interaction, and possibly explaining their cellular selectivity when it comes to the
antiproliferative activity displayed in the different cell lines.
■ INTRODUCTION
Molecular imaging is becoming one of the most important
techniques within the development of novel treatments in
medicine.1 This technique involves a noninvasive study of the
biological processes in vivo at a cellular level, rendering highly
precise information. The key role would be the design of
imaging agents that, combined with drugs, make them visible,
quantifiable, and traceable over time. In this way, the
development and optimization of specific treatments would
be easier and more effective. Within this framework, the design
of luminescent and bioactive heterometallic complexes offers a
clear advantage over monometallic or organic molecules.2 It
can be hypothesized that the inherent properties of each
metallic fragment are prone to be modulated separately. Later,
when both fragments are combined, a synergistic effect would
be expected to take place, possibly intensifying their
therapeutic and traceability potential. In this particular regard,
luminescent d6 metal complexes combined with bioactive
Au(I) or Ru(II) species, analogues to Auranofin or RAPTA,
respectively,3 or just mimicking the coordination sphere of a
specific drug, have been demonstrated to fulfill the require-
ment for becoming traceable luminescent and bioactive
species, see Figure 1.4
In general, the use of luminescent d6 metal complexes in cell
imaging5 presents several advantages such as high photo-
stability that renders high robustness to reach the biological
targets intact. Additionally, they have long-lived phosphor-
escence that allows time-resolved detection, and their large
Stokes shifts do not allow self-quenching mechanisms to take
place. Both features improve the signal/noise ratio and as a
consequence deliver greater image resolution. In the specific
case of Re(I) complexes, the typical emissive structures are
those derived from fac-[Re(N^N)(CO)3(L)]
0/+, where N^N
represents a diimine ligand and L a halogen or a N-donor
ligand. The emissive behavior is normally attributed to a metal-
to-ligand-charge transfer (3MLCT) transition, where the
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orbital of the diimine ligand is the main ligand contributor.6 In
addition, in the recent years some rhenium tricarbonyl species
have also showed antiproliferative potential in a wide range of
tumor cancer cell lines,7 which could be used as a great input
in the design of novel metallic drugs. Different combinations of
Re(I)/Au(I) complexes have been described in the literature
as promising candidates for trackable anticancer drugs. Figure
2 shows some examples of heterometallic fac-[Re(bipy)-
(CO)3(L-AuPPh3)]
+ complexes, where an imidazole derivative
or an alkynyl-pyridine derivative was used as a linker between
both metallic fragments.8 These heterobimetallic complexes
were proven to bear good cytotoxicity against A549 lung
cancer cells coming almost exclusively from the bioactive
Au(I) fragment. Also some analogues derived from [( fac-
[Re(bipy)(CO)3(L)])2Au]
3+ where L is a ditopic P,N-donor
ligand have shown their suitability as trackable bioactive
species. In all cases, the fac-{Re(bipy)(CO)3} core was
providing the traceability potential.9
In the search for the ultimate probe, it would be ground-
breaking to be able to detect the precise moment of the
interaction with the biological target. For doing so, a clear
change of the emissive properties of the luminescent tag would
be ideal. Such a change could be achieved if the interaction
with the biological target directly affects the emissive orbitals of
the luminescent tag. In the case of relying on Re(I) derivatives
for the traceability, a wise approach would be to introduce the
bioactive fragment within the diimine ligand, whose orbitals
are the main ligand orbitals implicated in the emissive
transition, i.e., 3MLCT. Therefore, it can be expected that
once the complex reaches the biological target and the
chemical transformation occurs between the bioactive frag-
ment and the biological target, the emission would be clearly
modified. The information obtained from this interaction
could be used later to structurally refine the bioprobe in order
to maximize the therapeutic potential. Thus, this work aims to
develop the first heterotrimetallic probes able to expose
precisely the right time of reaching and/or interacting with the
biological target.
■ RESULTS AND DISCUSSION
Synthesis and Characterization. Selected bioactive
Au(I) fragments will be directly grafted onto the diimine
ligand of species derived from fac-[Re(LNN)(CO)3(L)]
0/+ to
allow detecting the precise moment of interaction of the probe
with the biological target.
In this context, 4,4′-dialkynyl-2,2′-bipyridine (LNN) was
chosen as the linker ligand between both metal fragments.
Thus, LNN allows a direct electronic communication between
both metals and any modification within the bioactive gold
fragment, either disconnection from the luminescent tag (the
Re(I) fragment) or replacement of the gold ancillary ligand for
a biomolecule or any other residue will directly have a
quantitative effect on the luminescence.
Starting from the 4,4′-dibromo-2,2′-bipyridine and following
the same procedure described by Grosshenny and co-
workers,10 LNN was synthesized, see Scheme 1. After that,
the Re(I) complex 1 was obtained by heating together
stoichiometric amounts of LNN and [Re(CO)5Cl] in methanol.
Subsequent additions of the different gold(I) substrates, either
[Au(acac)(PPh3)] in dichloromethane or the respective
chloride gold derivatives of 1,3-bis(2,6-diisopropylphenyl)-
imidazol-2-ylidene (IPr) and tert-buthylisocyanide CNtBu in
the presence of a base in methanol, delivered the expected
neutral heterotrimetallic complexes 2−4 respectively, see
Scheme 1.
At this point, the poor solubility of complexes 2−4 was
already evident, which represents a serious drawback when it
comes to test these species for biological applications.
Therefore, the synthesis of the corresponding cationic
Figure 1. Examples of luminescent bioactive heterobimetallic
species.3,4
Figure 2. Examples of Re(I)/Au(I) species.8,9
Scheme 1. Schematic Synthetic Route for the Preparation of
LNN and the Rhenium and Gold Complexes 1−4a
a(i) TMSA, [Pd(PPh3)2Cl2], CuI, DIPEA, THF; (ii) KF, MeOH;
(iii) [Re(CO)5Cl], toluene, 80 °C, 8 h; (iv) [Au(acac)(PPh3)],
DCM, rt, 3 h or [AuCl(IPr)], KOH, MeOH, rt, 24 h or
[Au(CNtBu)Cl], KOH, MeOH, rt, 1 night.
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complexes was attempted by treatment of the chloride
complexes 2−4 with silver triflate in acetonitrile, Scheme 2,
route A. In this way, the axial chloride ligand can be removed
as insoluble AgCl and a molecule of solvent (CH3CN) will be
coordinated to the rhenium metal center instead. Despite
several attempts with species 2−4, only in the case of complex
3 does the removal of the chloride and insertion of acetonitrile
succeed, leading to the formation of complex 5. Conversely,
the same reaction with complexes 2 and 4 afforded highly
insoluble solids which could not be characterized. It is known
that alkynyl gold complexes in the presence of a silver salt can
afford highly insoluble polymers by coordination of the silver
center to the alkynyl ligand and also establishing metallophilic
interactions with the gold metals.11 A similar explanation could
be thought of in the present case. The lesser steric hindrance of
PPh3 and CN
tBu in comparison with that of the IPr ligand
does not prevent the polymerization reaction to take place.
Alternatively, a different strategy was considered for the
preparation of the cationic compound derived from species 2
and 4, route B, Scheme 2. The abstraction of the chloride was
performed on the rhenium precursor 1, rendering the cationic
species 6. Then, coordination of the gold fragment was
performed using the same conditions described before in
Scheme 1 when complexes 2 and 4 were delivered, i.e.,
[Au(acac)(PPh3)] and [Au(CN
tBu)Cl] as gold reactants,
respectively. Unfortunately, only compound 7 was obtained.
This time the handicap was the presence of a chloride ligand
within the gold starting material, [Au(CNtBu)Cl]. Complex 6
is highly sensitive to the presence of chloride ligands in the
reaction media and compound 1 was obtained systematically,
Scheme 2, route B.
Then, eventually, four neutral (species 1−4) and three
cationic (5−7) metallic complexes were synthesized, five of
them being heterotrimetallic Re(I)/Au(I) species (2−5 and 7)
and two monometallic Re(I) based (1 and 6). All of them,
have been characterized by 1H and 13C{1H} NMR, FT-IR, and
UV−vis spectroscopy as well as mass spectrometry, corrobo-
rating the accomplishment of their synthesis. Additional
31P{1H} NMR was performed for complexes 2 and 7. Analysis
of the CO stretching frequencies (υ(CO)) of all the neutral
complexes showed strong CO stretching bands around 2010−
1885 cm−1, which corroborate the expected carbonyl facial
arrangements.12 Alternatively, those bands for species 5−7
appear at higher frequency, around 2032 and 1917 cm−1,
indicative of the less effective π-backbonding between the CO
and Re(I) center of cationic species. Moreover, heterometallic
complexes lack υ(H−CC) bands, which were observed for
their rhenium precursors 1 and 6 at 3222 and 3202 cm−1,
respectively, indicating the success in the incorporation of the
second metallic fragment. In all cases, 1H NMR spectra were
well-defined and showed the typical patterns for the bipyridine
derivative coordinated to a fac-Re(CO)3 core.
13 Specifically,
four set of peaks were observed in the aromatic area integrating
for two protons each. In addition to these aromatic protons,
also those belonging to the phenyl groups in complexes 2, 3, 5,
and 7 appeared as multiplets. As expected, 13C{1H} NMR
spectra also showed clearly the presence of a gold metal
fragment coordinated to the alkynyl carbon as the chemical
shift for those Csp atoms ranged from 99.5 to 110.2 ppm,
whereas their Re(I) precursors 1 and 6 were at 87.3 and 79.9
ppm, respectively, see Table 1. Additionally, 31P{1H} NMR
spectra of complexes 2 and 7 showed a single peak at 41.5 and
41.0 ppm, respectively, corresponding to each phosphorus
atom coordinated to a different gold(I) fragment. Further
analytical data provided by mass spectrometry corroborated
the accomplishment of the synthesis.
X-ray Diffraction. Single crystals suitable for X-ray
diffraction analysis of monometallic Re(I) complexes 1 and 6
were obtained by slow diffusion of pentane and ether into a
solution of DCM or chloroform, respectively. In addition to
them, the heterometallic complex 3 also gave suitable crystals
for X-ray diffraction by slow diffusion of hexane into an
acetone solution. Relevant crystallographic data are reported in
Table S1.
Complex 1 crystallized in a monoclinic crystal system with a
C2/c space group containing a Re(I) molecule together with a
cocrystallized chloroform molecule within the asymmetric unit.
As expected for these types of d6 metal complexes, the Re(I)
coordination sphere can be described as a distorted
octahedron, where the equatorial plane is formed by two
carbonyl ligands and the bipyridine group. The third carbonyl
together with the chloride ligand is placed in the apical axis.
The source of the octahedral distortion is mainly due to the
Scheme 2. Schematic Synthetic Procedure and Depiction of
Final Complexes (5, 6, and 7)a
a(i) AgOTf, CH3CN, 40 °C, 1 night; (ii) AgOTf, CH3CN, 65 °C, 1
night; (iii) [Au(acac)(PPh3)], CH3CN, rt, 3 h; (iv) [Au(CN
tBu)Cl],
KOH, MeOH, rt.
Table 1. Selected FTIR Stretching Bands (cm−1), 13C{1H}
NMR and 31P{1H} NMR (ppm) Chemical Shifts of 1−7
υ(C−O) υ(H−CC) 31P{1H} 13C{1H} (C7)
1 2016, 1884 3222 87.3
2 1998, 1884 41.5a 110.2a
3 2016, 1911, 1888 101.2c
4 2016, 1887 99.5d
5 2032, 1917 101.7b
6 2034, 1917 3220 79.9b
7 2029, 1905 41.0b 100.8b
a13C{1H} NMR and 31P{1H} NMR were recorded in dicloromethane-
d2.
b13C{1H} NMR and 31P{1H} NMR were recorded in acetonitrile-
d3.
c13C{1H} NMR and 31P{1H} NMR were recorded in acetone-d6.
d13C{1H} NMR and 31P{1H} NMR were recorded in chlorofom-d1.
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constriction given by the chelated ligand, whose bite angle is
75.0(1) instead of 90° for an ideal octahedral geometry. The
most relevant bond distances and angles are described in
Figure 3, and all of them are within the range of values found
for similar complexes.14 Complex 6 crystallized in a triclinic
crystal system with a P1̅ space group bearing two independent
Re(I) molecules within the asymmetric unit as well as their
corresponding triflate anion and a solvent pentane molecule.
Once again, the Re(I) coordination sphere is described as
distorted octahedron, following the same ligand distribution
pattern seen for complex 1, except for the chloride ligand
which now is substituted by an acetonitrile molecule bound to
the metal center through the nitrogen atom (Figure 3 right and
S1). Similarly, the octahedral distortion comes from the bite
angle of the LNN, close in both cases to 75°. The angles and
bond distances for both Re(I) molecules within the
asymmetric unit are very similar, being in both cases the
longer Re−N and Re−C bond distances, these of the nitrogen
belonged to the acetonitrile and carbon from the axial carbonyl
ligand, respectively. The most relevant bond distances and
angles are described in Figure 3 (right structure) and Figure
S1.
Alternatively, the heterotrimetallic species 3 crystallized in
an orthorhombic crystal system and in a Pnma space group
together with a molecule of acetone from the crystallization
solvent mixture. The asymmetric unit is formed by half of a
molecule, denoting the symmetry of the structure. As in
previous examples, the rhenium metal center is disposed in an
octahedral environment with a N−Re−N angle of 75.1(3)°. As
expected, the gold atoms are coordinated in a linear fashion to
the terminal alkynyl carbon and the carbene carbon with a
C(1)−Au(1)−C(10) angle of 173.8(4). Relevant bond
distances and angles can be seen in Figure 4. The chlorine
and a carbonyl ligands coordinated to rhenium atom in trans
positions have been found to be disordered. They have been
included in the model in two sets of positions, but only one is
shown in the drawing and in the distances and angles below.
Photophysical Studies. UV−vis absorption spectra were
recorded for complexes 1−7 in a dimethyl sulfoxide solution at
298 K, see Table 2 and Figure S2. All of them showed a similar
absorption profile that can be defined as a combination of
ligand centered transitions (1LC) at higher energies and a
metal-to-ligand charge transfer transition (1MLCT) at lower
energies. Specifically, the absorption bands observed at
approximately 270 nm and between 300 and 350 nm can be
assigned to π → π*(bipy, Ph) and π → π*(CC) transitions,
in concordance with similar alkynylbisimine Re(I) derivatives
described in the literature.15 Additionally, the broad band close
to 400 nm, with a tail up to 450 nm in some cases, is attributed
to Re(dπ) → L(π*) transitions. The extended tail of this
1MLCT band is probably due to the extended electronic
delocalization among the alkynylbipyridine derivatives. In
addition to the absorption measurements, emission measure-
ments for all the species were analyzed in dimethyl sulfoxide at
298 K, Figure 5, and the most relevant data are collected in
Table 2. Their emission patterns are alike, a broad emission
band with the maxima between 565 and 680 nm, and the
lifetime value ranges from 12 to 302 ns. As expected, cationic
species have their maxima blue-shifted in comparison with
their neutral counterparts16 due to the less electron density on
Figure 3. Povray view of one of the Re(I) molecules present in the
asymmetric unit of complex 1 (left). Most relevant bond distances
(Å) and angles (deg): Re(1)−C(1) 1.928(5), Re(1)−C(2) 1.923(6),
Re(1)−C(3) 1.933(4), Re(1)−N(1) 2.170(4), Re(1)−N(2)
2.165(4), Re(1)−Cl(1) 2.477(4); N(1)−Re(1)−N(2) 75.0(1),
N(1)−Re(1)−C(1) 176.4(1). Povray view of one of the Re(I)
molecules present in the asymmetric unit of complex 6 (right). Most
relevant bond distances (Å) and angles (deg): Re(1)−C(1) 1.917(4),
Re(1)−C(2) 1.931(4), Re(1)−C(3) 1.923(4), Re(1)−N(1)
2.132(3), Re(1)−N(2) 2.161(3), Re(1)−N(3) 2.179(3); N(3)−
Re(1)−N(2) 75.30(11), N(1)−Re(1)−C(1) 175.77(15). Triflate
counterion has been removed for clarity.
Figure 4. Povray view of complex 3. Most relevant bond distances
(Å) and angles (deg): Re(1)−C(8) 1.912(9), Re(1)−C(9) 1.99(5),
Re(1)−Cl(1) 2.408(7), Re(1)−N(1) 2.165(6); N(1)−Re(1)−N(1)
75.2(4), N(1)−Re(1)−C(8) 99.2(4), N(1)−Re(1)−C(9) 87.9(3),
Cl(1)−Re(1)−C(9) 176.1(7); C(1)−Au(1) 1.998(9), C(10)−Au(1)
2.024(9); C(1)−Au(1)−C(10) 173.8(4).
Table 2. Absorption, Emission, Excitation Maxima of 1−7 in
DMSO Solution at 298 K
complex λabs/nm (10
4 ε/dm3 × mol−1 × cm−1)
λem/nm (λem/
nm) τ/ns
1 261 (2.03), 308 (1.33), 333 (0.88),
398 (0.40)
680 (468) 12
2 276(4.23), 304(4.25), 340 (2.39),
395 (1.26)
651 (473) 80
3 272 (3.65), 310 (4.34), 343 (2.44),
385 (1.07)
635 (451)
4 273 (3.66), 304 (4.99), 340(2.33),
390 (1.11)
663 (477) 44
5 272 (1.59), 289 (1.78), 306 (1.18),
345 (1.88)
565 (401)
6 262 (2.93), 323 (1.42), 338 (1.51),
356 (0.67)
619 (437) 123
7 270 (3.31), 301 (3.33), 344 (2.17),
373 (1.15)
585 (421) 302
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the metal center that ultimately stabilizes the HOMO orbitals.
In all cases the emission can be assigned to a 3MLCT
transition from the dπ(Re) → π*(diimine), which has been
previously reported in many rhenium(I) diimine tricarbonyl
analogues.6 It is worth noticing that the heterotrimetallic
analogues, both the neutral 2−4 and the cationic 5 and 7,
presented their maxima at higher energies than their
monometallic Re(I) precursors, complexes 1 and 6,
respectively. Such behavior has been already seen for similar
Re(I)/Au(I) species,15,17 and it can be explained based on the
additional electron density that the gold fragment renders to
the diimine. Higher electron donation into the diimine
promotes the destabilization of the LUMO orbital, which is
mainly centered in this ligand. Thus, the gold ancillary ligand
nature and its ability to donate or withdraw electron density
can be used to fine-tune the emission of the complexes, see
Table 2.18 On the basis of these data, if there was a breakage or
decoordination of the gold fragment or even substitution of the
gold ancillary ligand when the interaction with the biological
target takes place, fluorescence spectroscopy would allow
detection of the precise moment of such an interaction, which
was one of the requirements for the devised probes.
Antiproliferative Studies. The antipoliferative activity of
complexes 1 to 7 was analyzed by MTT assay in the human
lung cancer and breast cancer cell lines, A549 and HeLa, see
Table 3. The experiments were performed at different
incubation times, 24 and 72 h, as it is known that alkynyl
gold derivatives need longer times to reveal their cytotoxicity
in comparison to auranofin analogues (-SAuP-) or bi-
sphosphines (PAuP) derivatives.19 The fact that the gold−
carbon bond in alkynyl gold complexes is one of the strongest
gold−ligand bonds20 might be the driving force for delayed
time action. There is a clear difference between the
antiproliferative activity of monometallic and heterometallic
complexes, presenting the later higher cell selectivity toward
HeLa cells at longer times. Moreover, greater cytotoxicity was
seen for the cationic over neutral species. Specifically, the
heterotrimetallic neutral complexes 2 and 4 showed selective
antiproliferative activity after 72 h in the HeLa cell line, with
IC50 values of 6.46 and 10.79 μM, respectively, whereas in the
case of complex 3 the IC50 value was over 25 μM. On the
contrary, the neutral Re(I) precursor, complex 1, already
showed antiproliferative activity in A549 at 72 h as well as in
HeLa cells at 24 h. The same trend has been shown by the
cationic Re(I) complex 6, in this case with excellent IC50 values
(<8 μM) probably because of its higher solubility. Regarding
the cationic heterotrimetallic species, complexes 5 and 7, the
selectivity toward inhibiting the proliferation of HeLa cells was
not as evident as for their neutral analogue complexes 2−4,
since complex 7 already showed a moderate cytotoxicity in
A549 at 72 h and HeLa cells at 24 h (ca. 18 μM). However, it
is clear that the mechanism of action of the heterotrimetallic
probes involves somehow the gold fragment, which is what
ultimately is providing the cell selectivity at longer times.
Otherwise, the IC50 values of heterometallic complexes would
be similar to those of their parent monometallic Re(I)
complexes, where time dependence and cell selectivity were
not clearly displayed. A closer look at the IC50 values also
suggests that the gold ancillary ligands influence the cytotoxic
behavior following the trend −PPh3 > −CNtBu > −IPr, where
the phosphine derivative is the most cytotoxic. Their role in
the mechanism of action, or the way that they interfere within
the internalization process of the probe might explain such
behavior. Gold ancillary ligands are able to modulate the
cellular uptake considerably due to their different lipo- or
hydrophilic character, which is crucial for delivering the
cytotoxic agent.21
In addition, the intracellular amount of Au(I) was analyzed
by ICP-mass spectrometry for analogous neutral and cationic
heterometallic complexes, species 2 and 7, respectively, in
HeLa cells. The analyses showed that the cellular uptake of
gold was double for 7 than that for 2, revealing the importance
of the cationic nature for the internalization of the complexes,
see Table 4. Moreover, it is worth mentioning that IC50 values
are a combination of the intrinsic toxicity of the samples and
their ability of internalization and solubility in biological
media.22 Therefore, it seems clear that in this case, the ratio of
toxicity for cationic to neutral complexes is higher than the
ratio of uptake, corroborating that the intrinsic cytotoxicity of
cationic species is greater than that of their neutral counter-
parts.
Fluorescence Microscopy. Cell distribution of complexes
1−7 was studied by fluorescence microscopy in A549 cells. In
addition to them, either LysoTracker or MitoTracker were
used as an internal standard to ascertain the localization
pattern of the metallic species. Specifically, cell images were
recorder after incubating 1−7 at 25 μM for 24 h in order to
Figure 5. Normalized emission spectra for complexes 1−7 in
dimethyl sulfoxide at 298 K.
Table 3. IC50 values (μM) of Complexes 1−7 Measured by
MTT in A549 and HeLa Cells after 24 and 72 h Incubation
A549-24 h A549-72 h HeLa-24 h HeLa-72 h
1 >25 18.51 ± 3.71 17.01 ± 1.84 7.15 ± 0.47
2 >50 >25 >25 6.46 ± 0.35
3 >50 >25 >25 >25
4 >50 >25 >25 10.79 ± 0.48
5 >25 >25 >25 16.4 ± 2.80
6 8.37 ± 0.29 4.92 ± 0.38 5.10 ± 0.45 1.16 ± 0.13
7 >25 17.52 ± 1.40 18.8 ± 1.15 2.35 ± 0.06
Table 4. Quantity of Gold (μM) Measured Inside HeLa
Cells by ICP Mass Spectrometry after Incubation for 4 h
complex μg gold/105 cells
2 1.420 ± 0.014
7 2.207 ± 0.017
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not greatly increase the IC50 concentration. The irradiation
wavelength used was thoroughly selected depending on their
specific excitation and emissive properties, i.e., λexc = 474 nm,
and collecting the emission between 490 and 590 nm for
neutral and λexc = 405 nm and the emission window between
550 and 650 nm for cationic species.
In general, precipitation of the complexes was observed in
the extracellular region, which prevailed over accumulation
inside the cell, particularly evident for those complexes of a
neutral nature, 1−4, incubated at a high concentration in
A549. Figure 6 showed an example of the extracellular
precipitate of complexes 1 and 2.
Moreover, a comparison between the images recorded for
complexes 1 and 2 (Figure 6) and for complexes 3 and 4
(Figure S3), the four of them incubated with A549 cells under
the same conditions, clearly showed the lower solubility
properties of species 3 and 4. Therefore, it can be suggested
that the gold ancilliary ligands of complexes 3 and 4, i.e., IPr
and CNtBu, greatly contributed to the low solubility of the
compounds. The cationic species 5 and 7 followed a similar
trend as their neutral counterparts when incubated with A549
cells, and only the precipitated complex was clearly seen in the
surroundings of the cells, see Figure S4. Alternatively, the
monometallic rhenium complex 6 incubated in A549 at 25 μM
led directly to cell death, see Figure 7, corroborating the low
IC50 value of 8.37 ± 0.29 μM found for this particular species.
In addition to the analysis of the distribution of complexes
1−7 in A549 cells, further fluorescence microscopy studies
were performed in HeLa cells to evaluate the higher
antiproliferative activity displayed in this cell line. Thus,
complexes 1−7 were incubated with HeLa cells for 24 h, this
time at 5 μM in order to prevent a high percentage of cell
death. Analogous to the previous image assay, a considerable
amount of precipitate was observed in the outer cell membrane
media for the heterotrimetallic species. The main difference
with the previous experiment (see Figure 6 and S3) is that
most of the precipitate is located very close to the cell
membrane, see Figures 8 and S5. Therefore, it seems plausible
to think that an interaction with the membrane of HeLa cells
could be taking place. Despite that, none of the species could
be seen inside the cell, and elucidation of their inner
distribution or interaction could not be made. The fact that
no heterotrimetallic complex was seen inside the cell could be
due to either poor cell permeability, low emission efficiency, or
even emission quenching processes.
In a final attempt to shed a bit of light on the different
antiproliferative characters of the heterotrimetallic complexes
in HeLa cells in comparison with A549, a different experiment
was performed. This time the complexes were incubated with
HeLa cells at 25 μM while reducing the incubation time to 4 h
in order not to disrupt the cell viability. The experiment was
only performed for the cationic species (5−7) due to the low
solubility displayed for the neutral species in the previous
assays as well as their lower internalization found by ICP-mass
spectrometry. Thus, monometallic Re(I) complex 6 revealed
the cell immersed in a cell death process, which corroborates
the high cytotoxicity observed for this complex in HeLa cells at
Figure 6. Images of 1 (top row) and 2 (botton row) after incubation
with A549 (24 h) and LysoTracker Red-DND99 (30 min). (A) Image
after irradiation at 473; (B) after irradiation at 588 nm; (C)
superimposition picture of A and B; (D) superimposition with bright
field image. Green, complexes 1 and 2; red, internal standard.
Figure 7. Complex 6 incubated with A549 at 25 μM for 24 h.
Figure 8. Images of 2 (top row) and 4 (botton row) after incubation
with HeLa (24 h) at 5 μM and MitoTracker Red (15 min). Red
emission: MitoTracker. Green emission of complexes 2 and 4. (A)
Emission of the complex 2 and MitoTracker; (B) superimposition
with bright field. (C) Emission of the complex 4 and MitoTracker;
(D) superimposition with bright field image.
Inorganic Chemistry pubs.acs.org/IC Article
https://dx.doi.org/10.1021/acs.inorgchem.0c00813
Inorg. Chem. XXXX, XXX, XXX−XXX
F
only 24 h of incubation (5.10 ± 0.45 μM), see Figure 9. No
solid was observed outside the cell, suggesting that the
complex has been internalized.
Following the same trend as before, when incubated at 5
μM, cationic species 5 and 7 got stuck and/or adhered to the
outer part of the cell membrane, see Figure 10. Such a
localization pattern on HeLa cells, completely different from
that seen in A549 cells, where the solid was randomly
distributed through the outer cell media (Figure S4), might be
the key for the higher selectivity and cytotoxicity seen toward
the HeLa cell line. In addition, it is worth noticing that the
presence of the gold fragment is somehow implicated in such a
localization pattern, since the monometallic Re(I) species
complex 6 behaves completely differently and no solid is
distributed within the surroundings of the cell, Figure 9 vs
Figure 10. Therefore, it can be concluded that the mechanisms
of action of monometallic rhenium and trimetalllic rhenium/
gold derivatives differ from each other. Moreover, it is feasible
to think that the gold fragment is the driving force toward the
cell selective cytotoxicity and that differences in the membrane
composition of HeLa and A549 cells might be encouraging
such differentiation. In fact, cancer cells present lipid
alterations in their cell membrane.23 Studies have shown
variations of phospholipid-to-protein, cholesterol-to-protein,
and cholesterol-to-phospholipid ratios, as well as in the fatty
acid composition of the phospholipids of different cancer cell
line membranes,24 which in this case must be critical for the
cell specificity of our heterometallic probes.
■ EXPERIMENTAL SECTION
General Measurements and Analysis Instrumentation. Mass
spectra were recorded on a Bruker Esquire 3000 Plus, with the
electrospray (ESI) technique, and on a Bruker MALDI-TOF device.
1H, 13C{1H}, and 31P{1H} NMR, including 2D experiments, were
recorded at room temperature on a Bruker Avance 400 spectrometer
(1H, 400 MHz, 13C, 100.6 MHz, 31P, 162 MHz) with chemical shifts
(δ, ppm) reported relative to the solvent peaks of the deuterated
solvent. Infrared spectra were recorded in the range 4000−250 cm−1
on a PerkinElmer Spectrum 100 FTIR spectrometer. Room
temperature steady-state emission and excitation spectra were
recorded with a Jobin-Yvon-Horiba fluorolog FL3-11 spectrometer
fitted with a JY TBX picosecond detection module. Nanosecond
lifetimes were recorded with a Datastation HUB-B with a nanoLED
controller and DAS6 software. The nanoLEDs employed for lifetime
measurements were of 370 and 390 nm. The lifetime data were fitted
using the Jobin-Yvon software package and the Origin Pro 8 program.
UV−vis spectra were recorded with 1 cm quartz cells on an Evolution
600 spectrophotometer. The quantum yields were measured in a
300−950 nm Hamamatsu Photonics Quantaurus-QY.
Crystal Structure Determinations. Crystals were mounted in
inert oil on glass fibers and transferred to the cold gas stream of an
Xcalibur Oxford Diffraction diffractometer or Bruker Apex Duo
equipped with low-temperature attachments. Data were collected
using monochromated Mo Kα radiation (λ = 0.71073 Å). The scan
type was ω. Absorption correction based on multiple scans was
applied using spherical harmonics implemented in the SCALE3
ABSPACK scaling algorithm25 or with SADABS. The structures were
solved by direct methods and refined on F2 using the program
SHELXL-2016.26
Antiproliferative Studies: MTT Assay. Exponentially growing
cells (A549 or HeLa) were seeded at a density of approximately 104
cells per well in 96-well flat-bottomed microplates and allowed to
attach for 24 h prior to the addition of compounds. The complexes
were dissolved in DMSO and added to cells in concentrations ranging
from 50 to 0.5 μM or by 25 to 0.5 0.5 μM, in quadruplicate. Cells
were incubated with our compounds for 24 or 72 h at 37 °C. Ten
microliters of MTT (5 mg mL−1) was added to each well, and plates
were incubated for 2 h at 37 °C. Finally, the growth medium was
eliminated, and DMSO (100 μL per well) was added to dissolve the
formazan precipitates. The optical density was measured at 550 nm
using a 96-well multiscanner autoreader (ELISA). The IC50 was
calculated by nonlinear regression analysis.
ICP-Mass. Twelve-well plates were seeded with 105 cells (Hela/
A549) in 1.6 mL of culture medium per well. Cultures were incubated
at 37 °C in an atmosphere of 5% CO2/95% for 24 h. The culture
medium was then removed and replaced with 2 mL of drug
containing medium at 25 μM. After 4 h of incubation at 37 °C, the
medium was removed and the cell monolayer washed two times with
phosphate-buffer saline. Then, 1 mL of a trypsine solution was added,
and the plate was placed in the incubator for 5 min. A total of 500 μL
Figure 9. Images of 6 after incubation with HeLa (4 h) at 25 μM.
Figure 10. Images of 5 (top row) and 7 (botton row) after incubation
with HeLa (4 h) at 25 μM and MitoTracker Red (15 min). Red
emission: MitoTracker. Green emission of complexes 5 and 7. (A)
Emission of the complex 5 and MitoTracker; (B) superimposition
with bright field. (C) Emission of the complex 7 and MitoTracker;
(D) superimposition with bright field image at 25 μM for 4 h.
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of fresh medium was then added, and the resulting suspension was
pelleted in a 1.5 mL eppendorf by centrifuging for 5 min at 1200 rpm.
The pellets were resuspended in 500 μL of fresh medium, and a 50 μL
fraction was separated for cell counting after staining with Trypan
Blue. The suspension was centrifuged again. The medium was
removed, and 0.5 mL of concentrated aqua regia was added for
digestion overnight. The resulting solutions were diluted gravimetri-
cally with ultrapure water and analyzed by ICP-MS. Measurements
were performed by an ICP quadrupole mass spectrometer (Elan
DRC-e, PerkinElmer, Shelton, CT, USA) equipped with a standard
ICP torch, cross-flow nebulizer, nickel sampler, and skimmer cones
and DRC. PTFE vessels, micropipette tips, eppendorfs for digestion,
and polypropylene (PP) tubes were cleaned in 10% HNO3 overnight
and rinsed thoroughly with ultrapure water.
Cell Fluorescence Microscopy Study. The European Collection
of Cell Cultures was maintained in HEPES modified minimum
essential medium (DMEM) supplemented with 5% fetal bovine
serum, penicillin, and streptomycin. A549 cells were detached from
the plastic flask using trypsin-EDTA solution and suspended in an
excess volume of growth medium. A total of 300 μL of a
homogeneous cell suspension was then distributed into an μ-slide 8
well ibiTreat; the cells were allowed to attach for 24 h prior to the
addition of compounds. Then, 200 μL of culture medium was
removed, and 100 μL of a solution of the corresponding complexes
was added to the cells up to a final concentration of 5 or 25 μM. The
complexes were incubated with the cells for 4 or 24 h at 37 °C,
depending on the experiment. Thereafter, 50 μL of MitoTracker Red
or LysoTracker Red DND-99 was added up to a final concentration of
10 nM. They were incubated with the cells for 15 min (MitoTracker)
or 30 min (LysoTracker) at room temperature. Eventually, the
medium was replaced with fresh medium without phenol red.
Preparations were viewed using an Olympus FV10-i Oil type compact
confocal laser microscope using a ×10 or ×60 objective, with
excitation wavelengths at 405, 473, and 588 nm.




were prepared according to literature procedures, and their
experimental data agree with those reported.27−30 All other starting
materials and solvents were purchased from commercial suppliers and
used as received unless otherwise stated.
Synthesis of Complex 1. 4,4′-Alkynyl-2,2′-bipyridine (LNN; 129
mg, 0.632 mmol) and [Re(CO)5Cl] (228.7 mg, 0.632 mmol) were
suspended in toluene (10 mL) and heated at 80 °C for 8 h. The
suspension was cooled to room temperature, and the solid was filtered
and then washed with a small amount of toluene and petroleum ether.
The compound was obtained as an orange solid (306.3 mg, 95%). 1H
NMR (400 MHz, CDCl3): δ 9.01 (d, J = 5.8 Hz, 2H, H6), 8.20 (sbr,
2H, H3), 7.55 (dd, J = 5.8, 1.7 Hz, 2H, H5), 3.65 (s, 2H, H8).
13C
NMR (101 MHz, CDCl3): δ 196.9 (s, CO), 190.3 (s, CO), 155.3 (s,
2C, C6), 153.2 (s, 2C, C2), 133.9 (s, 2C, C4), 129.6 (s, 2C, C3), 128.3
(s, 2C, C8), 125.7 (s, 2C, C5), 87.3 (s, 2C, C7). IR (υ, cm-1): 3222
(CC−H), 3056 (CAr−H), 2107 (CC), 2016, 1884 (CO), 1605
(CArN). HRMS (m/z): 532.9685 [M − Cl + Na],
C17H8ClN2NaClO3Re (532.9664).
Synthesis of Complex 2. To a stirred solution of complex 1 (13
mg, 0.0255 mmol) in DCM (2.5 mL) was added [Au(acac)(PPh3)]
(28.2 mg, 0.051 mmol). After 3 h of stirring at room temperature, the
solvent was reduced to minimum volume, and petroleum ether was
added to afford a yellow solid (yield 28.6 mg, 79%).1H NMR (300
MHz, CD2Cl2): δ 8.78 (d, J = 5.8 Hz, 2H, H6), 8.10 (d, J = 1.7 Hz,
2H, H3), 7.63−7.45 (m, 30H, HAr, Ph), 7.41 (dd, J = 5.8, 1.6 Hz, 2H,
H5).
13C NMR (75 MHz, CD2Cl2): δ 198.47 (s, CO), 155.85 (s, 2C,
C2), 152.76 (s, 2C, C6), 137.62 (s, 2C, C4), 134.86 (d,
2J P−C = 13.8
Hz, 12C, o-C, Ph), 132.38 (s, 12C, p-C, Ph), 129.99 (d, 1J P−C = 57.3
Hz, 6C, i-C, Ph), 129.86 (d, 2J P−C = 11.3 Hz, 12C, m-C, Ph), 129.86
(s, 2C, C5), 126.37 (s, 2C, C3), 110.60 (s, 1C, C8), 100.22 (s, 1C, C7).
31P NMR (121 MHz, CD2Cl2): δ 41.5 (s). IR (υ, cm
−1): 3046 (CAr−
H), 2107 (CC), 1998, 1884 (CO), 1600 (CArN). MALDI-
HRMS (m/z): 1391.1089 [M−Cl], C53H36Au2N2O3P2Re
(1391.1090).
Synthesis of Complex 3. To a stirred solution of complex 1 (15
mg, 0.0294 mmol) and [AuClIPr] (36.6 mg, 0.589 mmol) in MeOH
(5 mL) was added a solution of KOH (3.87 mg, 0.0588 mmol) in
MeOH (3 mL). The mixture was stirred 24 h at room temperature
and then purified by alumina column chromatography employing
ether/MeOH (97:3 to 93:7). The product was obtained as a yellow
solid (yield 22.4 mg, 45%). 1H NMR (300 MHz, acetone-d6): δ 8.67
(dbr, J = 5.8 Hz, 2H, H6), 8.22 (dbr, J = 1.6 Hz, 2H, H3), 7.81 (s, 4H,
H10), 7.61 (t, J = 7.8 Hz, 4H, H14), 7.45 (d, J = 7.8 Hz, 8H, H13), 7.24
(dd, J = 5.8, 1.6 Hz, 2H, H5), 2.72 (t, J = 6.9 Hz, 4H, H15), 2.68 (t, J =
6.9 Hz, 4H, H15), 1.39 (d, J = 6.9 Hz, 24H, CH3), 1.27 (d, J = 6.9 Hz,
24H, CH3).
13C NMR (101 MHz, acetone-d6): δ 199.26 (s, CO),
191.08 (s, CO), 189.94 (s, 2C, C9), 156.34 (s, 2C, C2), 152.64 (s, 2C,
C6), 148.63 (s, 2C, C8), 146.68 (s, 4C, C12), 139.06 (s, 2C, C4),
135.40 (s, 4C, C11), 131.41 (s, 2C, C14), 129.78 (s, 2C, C5), 126.91
(s, 2C, C3), 125.32 (s, 4C, C10), 125.00 (s, 8C, C13), 101.18 (s, 2C,
C7), 24.91 (s, 8C, CH3), 24.13 (s, 8C, CH3). IR (υ, cm
−1): 2111
(CC), 2016, 1911, 1888 (CO), 1603 (CAr=N).
Synthesis of Complex 4. To a suspension of complex 1 (40 mg,
0.078 mmol) and tert-butylisocyanide gold chloride (49.5 mg, 0.157
mmol) in MeOH (5 mL) was added a solution of KOH (10.3 mg,
0.157 mmol) in MeOH (1 mL), and the mixture was allowed to react
for 12 h at room temperature. The solvent was then evaporated and
the residue dissolved in DCM. After filtration over Celite, the volume
was reduced to 1−2 mL, and ether was added to precipitate complex
4 as a yellow solid (yield 64.5 mg, 77%). 1H NMR (400 MHz,
CDCl3): δ 8.81 (d, J = 5.8 Hz, 2H, H2), 8.04 (d, J = 1.6 Hz, 2H, H5),
7.38 (dd, J = 5.8, 1.6 Hz, 2H, H3), 1.60 (s, 18H, H11).
13C NMR (101
MHz, CDCl3): δ 197.52 (s, CO), 189.91 (s, CO), 155.37 (s, 2C, C6),
152.40 (s, 2C, C2), 137.34 (s, 2C, C9), 136.73 (s, 2C, C4), 129.58 (s,
2C, C3), 126.07 (s, 2C, C5), 99.50 (s, 2C, C7), 59.12 (s, 2C, C10),
29.94 (s, 6C, C11). IR (cm
−1): υ 2984 (Csp
3−H), υ 2231 (CN), υ
2119 (CC), υ 2016, 1887 (CO), υ 1603 (CArN).
Synthesis of Complex 5. To a stirred solution of 1 (1 equiv, 22.6
mg, 0.013 mmol) in acetonitrile (5 mL) was added AgOTf (1.1 equiv,
3.7 mg, 0.014 mmol), and the reaction mixture was allowed to react at
40 °C overnight. The suspension was then filtrated over Celite, and
the solvent was evaporated. The crude was washed with ether three
times to afford an orange solid corresponding to 5 (18.4 mg, 75%).
1H NMR (400 MHz, CD3CN): δ 8.64 (d, J = 5.8 Hz, 2H, H6), 8.11
(d, J = 1.6 Hz, 2H, H3), 7.64 (t, J = 7.8 Hz, 4H, H14), 7.54 (s, 4H,
H10), 7.46 (d, J = 7.8 Hz, 8H, H13), 7.28 (dd, J = 5.8, 1.6 Hz, 2H, H5),
2.62 (quint, J = 6.9 Hz, 8H, H15), 2.13 (s, 3H, H19), 1.37 (s, 12H,
CH3-IPr), 1.36 (s, 12H, CH3-IPr), 1.29 (s, 12H, CH3-IPr), 1.28 (s,
12H, CH3-IPr).
13C NMR (101 MHz, CD3CN): δ 189.34 (s, 2C, C9)
156.58 (s, 2C, C2), 153.84 (s, 2C, C6), 148.49 (s, C8), 147.01 (s, 8C,
C12), 139.47 (s, 2C, C4), 135.17 (s, 4C, C11), 131.66 (s, 4C, C14),
130.47 (s, 2C, C5), 127.54 (s, 2C, C3), 125.28 (s, 4C, C10), 125.17 (s,
8C, C13), 101.68 (s, 2C, C7), 29.63 (s, 8C, C15), 24.82 (s, 8C, CH3-
IPr), 23.99 (s, 8C, CH3-IPr). IR (cm
−1): υ 2961 (Csp
3−H), υ 2107
(CC), υ 2032, 1917 (CO), υ 1602 (CArN). MALDI: 1643.4.
Calcd M-NCCH3: 1643.5
Synthesis of Complex 6. To a stirred solution of 1 (1 eq, 50 mg,
0.098 mmol) in acetonitrile (5 mL) was added AgOTf (1.1 eq, 27.8
mg, 0.108 mmol), and the reaction mixture was allowed to react
overnight. The suspension was then filtrated over Celite and
concentrated, and ether was added to precipitate a yellow solid
corresponding to 6 (49.6 mg, 76%). 1H NMR (400 MHz, CD3CN): δ
8.98 (dd, J = 5.8, 0.6 Hz, 1H, H6), 8.58 (d, J = 1.1 Hz, 1H, H3), 7.74
(dd, J = 5.8, 1.6 Hz, 1H, H5), 4.16 (s, 1H, H8), 2.05 (s, 3H, H10).
13C
NMR (101 MHz, CD3CN): δ 156.93 (s, C2), 155.13 (s, C6), 135.75
(s, C4), 131.28 (s, C5), 128.14 (s, C3), 123.68 (s, C9), 89.28 (s, C8),
79.94 (s, C7), 3.99 (s, C10). IR (cm
−1): υ 3202 (Csp−H), υ 2104
(CC), υ 2034, 1917 (CO), υ 1609 (CArN). HRMS (m/z):
516.0341 M+, C19H11N3O3Re (516.0353)
Synthesis of Complex 7. To a stirred solution of 6 (1 equiv, 20 mg,
0.03 mmol) in acetonitrile (5 mL) was added [Au(acac)PPh3] (2
equiv, 33.6 mg, 0.06 mmol) with a change in the color of the solution
from yellow to brown. After 3 h of reaction, the solution was filtered
over Celite and concentrated, and ether was added to precipitate a
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light brown solid corresponding to 7 (39.3 mg, 83%). 1H NMR (300
MHz, CD3CN): δ 8.80 (d, J = 5.8 Hz, 2H, H6), 8.40 (s, 2H, H3),
7.65−7.50 (m, 16H, HAr + H5), 2.06 (s, 3H, H10). 13C NMR (75
MHz, CD3CN): δ 194.98 (s, CO), 191.73 (s, CO), 156.88 (s, 2C,
C2), 154.12 (s, 2C, C6), 138.81 (s, 2C, C4), 135.19 (s, 12C, o-C, Ph),
133.08 (s, 6C, p-C, Ph), 130.86 (s, 2C, C5), 130.57 (s, 12C, m-C, Ph),
127.69 (s, 2C, C3), 123.31 (s, C9), 100.82 (s, 2C, C7), 4.14 (s, C10).
31P NMR (121 MHz, CD3CN): δ 40.88 (s). IR (cm
−1): υ 3053
(Csp
2−H), υ 2108 (CC), υ 2029, 1905 (CO), υ 1600 (CArN).
MALDI: 1391.0. Calcd: M−NCCH3, 1391.1
■ CONCLUSIONS
In the search for a new family of metallic-based luminescent
anticancer agents that allow detection of the precise moment
of interaction with the biological target, three neutral and two
cationic heterotrimetallic Re(I)/Au(I) complexes were synthe-
sized together with their monometallic Re(I) precursors. A key
ligand, 4,4′-dialkynyl-2,2′-bipyridine (LNN), was used as a
linker between the two types of metals, coordinating the
rhenium atom through the nitrogen atoms in a bidentate mode
and the gold atoms through the terminal alkynyl carbons.
Either triphenylphosphine (PPh3), 1,3-bis(2,6-diisopropyl-
phenyl)-imidazol-2-ylidene (IPr), or tert-butyl isocyanide
(CNtBu) was used as a gold ancillary ligand in order to
modulate the luminescent and/or bioactivity of the probes. As
expected, all of them are emissive in the range of 565−680 nm,
and the emission, mostly due to the Re(I) fragment, was
assigned to a 3MLCT transition from the dπ(Re) → π*(LNN).
In addition, heterometallic species displayed a blue-shifted
emission in comparison with that of their monometallic Re(I)
counterparts. This fact could be ultimately used to monitor an
interaction between 2 and 5 or 7 with a biological target, if
such interaction promotes the release of the gold fragment.
Crystal structures were obtained for species 1, 3, and 6,
showing the expected facial disposition of the tricarbonyl
ligands and confirming the bidentate character of the LNN as
well as the linearity of the gold coordination mode. An
antiproliferative assay in A549 (lung cancer) and HeLa (cervix
cancer) cells revealed three important features: first, the
improvement in the cytotoxicity values of the cationic species
in comparison with their neutral equivalents; second, the
enhancement of the toxicity over time; and finally, the general
selectivity of the heterotrimetallic species toward HeLa cells
with the exception of complex 3. ICP-mass spectrometry
corroborated the greater cell internalization of the hetero-
metallic cationic species. Fluorescence microscopy assays were
performed to elucidate their distribution pattern and the
different cytotoxic behavior in both cell lines, A549 and HeLa.
The low solubility, especially that of neutral complexes, was
evident using this technique, as lot of solid was randomly seen
in the outside of the cells when incubated with A549. On the
contrary, for the heterotrimetallic species in HeLa cells, the
distribution of the complexes changed. In this case, the solid
was located very close, and possibly interacting with the outer
cellular membrane, which might be triggering the selectivity
and higher toxicity toward the HeLa cell line over A549. Such
behavior was not observed for the monometallic Re(I)
complexes, suggesting a different mechanism of action.
Therefore, the higher selectivity for HeLa over A549 cells
displayed by heterometallic species can be associated with the
gold fragment, which somehow is the main responsibility.
Possibly a different composition of HeLa and A549 cell
membranes makes possible such differentiation, causing the
heterotrimetallic species to be more sensitive toward HeLa cell
membranes. Future heterometallic probes, as in general any
species designed to become drugs, should consider solubility in
biological environments and targeting as one of their main
features to retain. For that, alternatives such as introducing
water-soluble groups or, even better, amino acid or small
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